Clinical Edge Journal Scan

Proximal and total gastrectomy with laparoscopy have similar outcomes in stage I gastric cancer


 

Key clinical point: Laparoscopic proximal gastrectomy (LPG) and laparoscopic total gastrectomy (LTG) lead to similar long-term outcomes and postoperative complications in patients with upper third clinical stage I gastric cancer.

Major finding: Patients who underwent LPG and LTG showed no significant difference in the 3-year overall survival (92.6% and 92.3%, respectively; P = .74), recurrence-free survival (both 85.3%; P = .72), early complication (eg, surgical site infection; P = .31), and late complication (eg, anastomotic stenosis; P = .31) rates.

Study details: This retrospective study propensity score-matched patients with upper third clinical stage I gastric cancer who underwent LTG (n = 28) and those who underwent LPG (n = 28).

Disclosures: No source of funding was reported. The authors declared no conflicts of interest.

Source: Yamamoto M et al. Laparoscopic proximal gastrectomy with novel valvuloplastic esophagogastrostomy vs laparoscopic total gastrectomy for stage I gastric cancer: A propensity score matching analysis. J Gastrointest Surg. 2022 (Aug 29). Doi: 10.1007/s11605-022-05404-y

Recommended Reading

Worse treatment response in KRASG12C-mutant metastatic CRC
MDedge Hematology and Oncology
Refractory mCRC: Trifluridine/tipiracil plus bevacizumab effective and safe in real world
MDedge Hematology and Oncology
Coadministration of H2RA may not reduce efficacy of capecitabine in early CRC
MDedge Hematology and Oncology
Elevated pretreatment plasma PD-L1 level indicates worse prognosis in mCRC
MDedge Hematology and Oncology
Intraperitoneal paclitaxel+XELOX: A promising treatment option for gastric cancer peritoneal metastases
MDedge Hematology and Oncology
Surveillance endoscopy warranted in individuals at high risk for gastric cancer
MDedge Hematology and Oncology
Advanced gastric cancer: TMB status associated with first-line pembrolizumab therapy outcomes
MDedge Hematology and Oncology
Standard duration of S-1 or CAPOX adjuvant chemotherapy strongly recommended for GC treatment
MDedge Hematology and Oncology
Locally advanced gastric cancer: Lymph node ratio a prognosticator after neoadjuvant chemotherapy
MDedge Hematology and Oncology
Perioperative treatment and minimally invasive surgery improve outcomes in operable gastric cancer
MDedge Hematology and Oncology